1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M


1 Year 1Y

5 Years 5Y

About Cardinal Health, Inc.

Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for healthcare facilities. With 50 years in business, operations in 46 countries and approximately 48,000 employees globally, Cardinal Health is essential to care.
Michael Kaufmann

7000 Cardinal Pl
Dublin, Ohio 43017-1091
Phone: 16147573033


Cardinal Health Issues $1.15 Billion Notes for Long-Term Growth
Feb 20, 2024 21:48pm

Cardinal Health (CAH) has released an update. Cardinal Health, Inc. recently concluded a significant public offering, issuing $1.15 billion in Note…

Cardinal Health: Continued Business Growth And Huge Medical Supplies Market Penetration
Feb 20, 2024 09:25am

No summary available.

Source:Seeking Alpha
Final Trades: Invescos Equal Weight Energy ETF, Cardinal Health and Shake Shack
Feb 15, 2024 18:06pm

Todays Halftime Report Investment Committee, Bryn Talkington, Josh Brown and Jason Snipe, give their top picks to watch for the second half.

Cardinal Health Stock Shows Healthy Improvement To Its Technical Strength
Feb 14, 2024 20:33pm

A Relative Strength Rating upgrade for Cardinal Health shows improving technical performance. Will it continue?

Source:Investor''s Business Daily
Q— —…—4 Cardinal Health Inc Earnings Call Transcript
Feb 10, 2024 04:50am

Q2 2024 Cardinal Health Inc Earnings Call Transcript

Argus upgrades Cardinal Health to buy, cites generics program
Feb 09, 2024 21:48pm

No summary available.

Source:Seeking Alpha
Insider Decision: Walgreens Boots Alliance Inc Offloads $991.64M Worth Of Cencora Stock
Feb 09, 2024 15:01pm

Walgreens Boots Alliance Inc , 10% Owner at Cencora (NYSE: COR ), executed a substantial insider sell on February 9, according to an SEC filing. What Happened: Inc''s decision to sell 4,212,395 shares of Cencora was revealed in a Form 4 filing with the U.S. Securities and Exchange Commission on Friday. The total value of the sale is $991,639,906. During Friday''s morning session, Cencora shares down by 0.0%, currently priced at $230.32. Delving into Cencora''s Background Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the U.S. pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health).

Argus upgrades Cardinal Health to Buy rating
Feb 09, 2024 13:42pm
Precipio and Cardinal Health Sign Distribution Agreement for its HemeScreen Portfolio of Molecular assays for Cancer
Feb 06, 2024 15:00pm

NEW HAVEN, Conn., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces it has entered into a distribution agreement with Cardinal Health for its HemeScreen molecular assay products. Under the agreement, Cardinal Health will market and distribute Precipio’s HemeScreen portfolio of molecular assays to its customer base, which comprises

Cardinal Health CEO Jason Hollar sits down with Jim Cramer
Feb 03, 2024 00:26am

Cardinal Health CEO Jason Hollar joins ''Mad Money'' host Jim Cramer to talk quarterly earnings, innovation, recent acquisitions and more.